‘I’m here today thanks to trials’

CANCER Research UK’s STAMPEDE trials have made exciting progress.

They are looking for new treatment combinations for prostate cancer – one of the most common forms in men.

Last summer, STAMPEDE scientists published encouraging results. They showed that giving men with a certain type and stage of the cancer two drugs – abiraterone and prednisolone – meant the disease was far less likely to spread or worsen.

Alfred Samuels, 59, is grateful to the trial. He said: “During the first six months, tests showed the treatment was working. I’m still on the trial which I find reassuring and my cancer is being managed well.

“If it wasn’t for abiraterone and Cancer Research UK, I don’t think I’d be here today.”